Cipla share price hits record high on DCGI nod to import Moderna vaccine to treat COVID-19; may rally 12% more

Cipla share price hit a new record high of Rs 997.20 apiece in intraday on BSE on Wednesday, after the DCGI approved the firm to import Moderna, a Covid-19 vaccine, with emergency use authorisation in India.

cipla, moderna, covid-19 vaccine

Cipla, HDFC among 4 technical stocks to buy; Nifty may go down to 15,450 if it falls below 15,670

According to options statistics and retracement levels, the Nifty / Sensex would find support at 15800/52800 and 15670/52300 levels.

Cipla, HDFC, housing development finance corporation, stock market

Price capping waiver to exemption from bridging trials – On Moderna’s entry in India, what Cipla told Modi govt

Cipla has also sought indemnity in case of any adverse effects or complications caused by the Moderna vaccine

The indemnity issue was being addressed and under consideration Paul said.

If Nifty holds above 15,500, it may hit 15,800; Bank Nifty looks positive; RIL, SBI stocks in focus this week

The chart pattern suggests that if Nifty crosses and sustains above 15500 level it would witness buying which would lead the index towards 15650-15800 levels

Nifty, bank nifty, open interest, Call OI, Put OI

Nifty may hit 16,400 by Sept, Bank Nifty may soar 11% to 38,600; Check ICICI Direct’s top stock picks

NSE Nifty 50 is expected to challenge its lifetime high of 15,431 points and soar to as high as 16,400 by September.

NSE Nfty 50, Bank Nifty, IT sector, stock market

Reliance Home, India Cements, Bharti Airtel, Cadila, Cipla, Panacea Biotec, Alembic Pharma stocks in focus

Nifty futures were trading 145 points or 0.95 per cent higher at 15,335 on Singaporean Exchange, suggesting a strong opening for BSE Sensex and Nifty 50

stocks in focus, Reliance home, bharti Airtel, cipla, cadila

Cipla की कोरोना टेस्ट किट Viragen लांच, 25 मई से शुरू होगी सप्लाई

दिग्गज दवा कंपनी Cipla ने कोरोना वायरस की टेस्टिंग के लिए अपना तीसरा प्रॉडक्ट पेश किया है

drug major Cipla launches RT-PCR test kit ViraGen in India partnership with Ubio Biotech

Analyst Corner: Maintain ‘buy’ on Cipla, raise TP to Rs 1,065

US on a steady growth path; sizeable launches lined up in FY23: Cipla continues to see strong traction for its gProventil (albuterol inhaler) launch in the US where it has garnered 13.2% volume share. 4Q US sales at $138 m de

Shares of Cipla closed at Rs 946.40 per scrip on BSE, down 0.29 per cent from its previous close.

Nifty may trade in 14,400-15,000 range this week, Bank Nifty below 20, 50, 100 day SMAs; Wipro, Cipla in focus

The chart pattern suggests that if Bank Nifty crosses and sustains above 33000 level it would witness buying which would lead the index towards 33500-34500 levels.

Nifty, bank nifty, stock markets

Bharti Airtel, Cipla, SBI, Gland Pharma, Tata Motors, L&T, Jindal Stainless stocks in focus

Monday could start on a positive note for domestic indices with the SGX Nifty gaining 58 points or 0.39 per cent on Singaporean Exchange during the early hours of trade. 

Bharti Airtel, Cipla, SBI, Gland Pharma, Tata Motors, stocks in focus

Quarterly Results: Cipla net profit surges 73% to Rs 412 crore in Q4 on robust sales

The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2019-20.

Cipla March quarter (Q4) results

L&T, Cipla, Lupin, Dr Reddy’s, Vedanta, GAIL, Tata Power, Reliance Infrastructure stocks in focus

Nifty futures were trading 191.50 points or 1.32 per cent higher at 14,699 on Singaporean Exchange, indicating a strong opening for BSE Sensex and Nifty 50

L&T, Cipla, Lupin, Dr Reddy's, Vedanta, stocks in focus

Stocks in focus: Easy Trip Planners IPO, Cipla, NMDC, Indian Oil, PVR, Reliance Home Finance

After gaining over 2.5 per cent in the previous week, BSE Sensex and Nifty 50 are set to start the week on a positive note on Monday

stocks in focus, Reliance home, NMDC

ICICI Bank, Infosys, among top large-cap stock picks in 2021 with over 13% potential upside

Indian share markets hit fresh record high yet again, with BSE Sensex ruling above 49,200 for the first time ever. The broader Nifty 50 index topped the crucial 14,450 level

stocks in focus, yes bank, maruti suzuki

Cipla shares: Analysts turn bullish on Cipla post Revlimid patent settlement; see nearly 30% rally

With Cipla having achieved a commanding market share in gProventil, US growth is now expected to be driven by market share gains from other Albuterol inhalers


Diwali technical stock picks: Buy these 5 shares for up to 30% rally in 3 months in Samvat 2077

Indian share markets rebounded sharply from March lows, and are now back to pre-COVID levels. Nifty 50 has rallied over 60 per cent from its 52-week low of 7511.

ICICI Bank, Cipla, Infosys, diwali

3 pharma stocks set to gain 25% as cardiac remains dominant therapy in Indian pharma market

According to the brokerage firm, Lupin, Glenmark, JB Chemicals, and Cipla are likely to gain market share among listed players.

UTI AMC, mazagon dock, IPO

Cipla shares hit new 52-week high, surge 128% since March; Morgan Stanley sees this much upside in stock

Cipla said that the company continues to closely monitor the impact of the coronavirus pandemic on all aspects of its business, including how it will impact its customers, employees, vendors and business partners

Stocks in focus: Glenmark Pharma, Cipla, Reliance Capital, HDFC Bank shares to remain in news today

Market sentiments would be swayed by global cues, development around geopolitical tensions, coronavirus cases, monthly F&O expiry and foreign fund movement

U.S. Stocks, Apple, Stock Split, iPhone maker, U.S. tech companies, U.S. tech stocks

Cipla, Ashok Leyland, Tata Chemicals, Escorts, agri stocks to remain in action today

Aarti Drugs, Cipla, Crompton Greaves, IIFL Securities, Nippon Life India Asset Management, Tata Chemicals and L&T Technology Services are among 12 companies that are scheduled to announce their March quarter earnings today.

Regeneron Pharmaceuticals, S&P 500, best performing stock, Netflix, Amazon,

Sun Pharma, Aurobindo Pharma among top stock picks from Pharma sector; CLSA sees gain up to 30%

Among pharma stocks, the top stock picks of CLSA are Sun Pharma, Cipla, Aurobindo Pharma and Cadila Healthcare, recommending a 'buy' rating on them

Cipla share price falls 5% after warning letter from US Food and Drug Administration

he USFDA had conducted an inspection at Cipla’s Goa facility in September last year. Cipla share price was down at Rs 406 on market opening.

Cipla board approves appointment of Dr Reddy’s Laboratories’ Kedar Upadhye as Global CFO

Drug firm Cipla today said its board has approved appointment of Kedar Upadhye as the company's Global Chief Financial Officer.

Delhi HC questions govt over urgency to ban over 300 FDC drugs

Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and Cipla

Delhi HC extends relief to pharma firms over drug ban

Several companies went to the Delhi High Court to try to get the ban lifted

11 stocks trending in Friday’s trade: Crompton Greaves, DLF and more

Healthcare majors, including Cipla, Lupin, Wockhardt, Glaxosmithkline and Mankind Pharma, on Thursday granted interim relief by Delhi High Court which stayed till March 21 the ban imposed by the Centre on sale of some of thei

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market

Most Read


Top News


Related Articles